Søk. Nøkkelinformasjon. Sammendrag og figur. Klasser. IPC-klasse. Søker. Finn patenter, varemerker og design i Norge

Transkript

1 Søk Finn patenter, varemerker og design i Norge Nøkkelinformasjon Databasen er sist oppdatert :58:00 Tittel Status Hovedstatus Detaljstatus Patentnummer Europeisk (EP) publiserings nummer HUMANE ANTISTOFFER SOM BINDER MESOTHELIN OG ANVENDELSER DERAV Aktiv EP patent gjort gjeldende i Norge EP patent besluttet gjeldende i Norge NO/EP EP EP inngitt EP søknadsnummer EP meddelt Prioritet Sakstype , P,, med flere Europeisk Løpedag Utløpsdato Allment tilgjengelig Meddelt Innehaver Oppfinner Fullmektig Lenke til European patent Register Patentfamilie Bristol-Myers Squibb Company () TERRETT, Jonathan A. () Tandbergs Patentkontor AS (NO) Informasjon i saken, dokumenter og patentfamilie Se i Espacenet Sammendrag og figur Se forsidefigur og sammendrag i Espacenet Klasser IPC-klasse C07K 16/30 A61K 39/00 A61K 39/395 A61K 47/48 A61P 35/00 C12P 21/08 Søker

2 Innehaver Europeisk innehaver: Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ Oppfinner TERRETT, Jonathan A. 510 N. Castelrock Terrace Sunnyvale, CA POGUE, Sarah L Midday Commons Fremont, CA TOY, Kristopher 521 Cottonwood Drive Milpitas, CA YANG, Lan Purissima Way Morgan Hill, CA RAO-NAIK, Chetana 565 Matterhorn Drive Walnut Creek, CA CHEN, Bingliang 118 Lawrence Road Alameda, CA Fullmektig Tandbergs Patentkontor AS Se mer Postboks 1570 Vika 0118 OSLO NO ( OSLO kommune, OSLO fylke ) Org.nummer: Referanse på sak: V2360NO00 Europeisk fullmektig: Tuxworth, Pamela M. J A Kemp 14 South Square Gray's Inn London WC1R 5JJ GB Prioritet

3 , P , P , P Anførte dokumenter WO-A1-2009/ (B1/EP) WO-A2-2006/ (B1/EP) WO-A2-2006/ (B1/EP) -A (B1/EP) -A (B1/EP) WO-A2-99/28471 (B1/EP) HASSAN RAFFIT ET AL: "Inhibition of mesothelin-ca-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.", LUNG CANCER (AMSTERDAM, NETHERLANDS) JUN 2010, vol. 68, no. 3, June 2010 ( ), pages , ISSN: (B1/EP) CHANG K ET AL: "CHARACTERIZATION OF THE ANTIGEN (CAK1) RECOGNIZED BY MONOCLONAL ANTIBODY K1 PRESENT ON OVARIAN CANCERS AND NORMAL MES0THELIUM", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER REREARCH, LNKD- DOI: /S X(08) , vol. 52, no. 1, 1 January 1992 ( ), pages , XP , ISSN: (B1/EP) BRINKMANN U ET AL: "Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesothelioma and ovarian cancers", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, UNITED STATES, SWITZERLAND, GERMANY LNKD- DOI: /(SICI) ( )71:4< 638::AID-IJC21>3.0.CO;2-6, vol. 71, no. 4, 1 January 1997 ( ), pages , XP , ISSN: (B1/EP) LI QIAN ET AL: "CYTOTOXIC ACTIVITY OF THE RECOMBINANT ANTI-MESOTHELIN IMMUNOTOXIN, SS1(DSFV)PE38, TOWARDS TUMOR CELL LINES ESTABLISHED FROM ASCITES OF PATIENTS WITH PERITONEAL MESOTHELIOMAS", ANTICANCER RESEARCH, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 24, no. 3A, 1 May 2004 ( ), pages , XP , ISSN: (B1/EP) HASSAN R ET AL: "ANTI-TUMOR ACTIVITY OF K1-LYSPE38QQR, AN IMMUNOTOXIN TARGETING MESOTHELIN, A CELL- SURFACE ANTIGEN OVEREXPRESSED IN OVARIAN CANCER AND MALIGNANT MESOTHELIOMA", JOURNAL OF IMMUNOTHERAPY: WITH EMPHASIS ON TUMOR IMMUNOLOGY, RAVEN PRESS,, vol. 23, no. 4, 1 July 2000 ( ), pages , XP , ISSN: (B1/EP) CHOWDHURY P S ET AL: "Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 20 JAN 1998 LNKD- PUBMED: , vol. 95, no. 2, 20 January 1998 ( ), pages , XP , ISSN: (B1/EP) NICOLAIDES NICHOLAS C ET AL: "MORAb-009, a monoclonal antibody that specifically targets mesothelin, a cell surface tumor adhesion molecule over-expressed in pancreatic, ovarian, and lung cancer and mesothelioma", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH,, vol. 48, 18 April 2007 ( ), pages , XP , ISSN: X (B1/EP) SHEEHAN PETER F J ET AL: "EFFECTS OF HISTAMINE AND 5-HYDROXYTRYPTAMINE ON THE GROWTH RATE OF XENOGRAFTED HUMAN BRONCHOGENIC CARCINOMAS", EXPERIMENTAL AND CLINICAL PHARMACOLOGY - EKSPERIMENTAL'NAA IKLINICESKAA FARMACOLOGIA, MOSCOW, vol. 23, no. 6-7, 1 January 1996 ( ), pages , XP , ISSN: (B1/EP) GUBBELS JENNIFER AA ET AL: "Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 5, no. 1, 26 October 2006 ( ), page 50, XP , ISSN: , DOI: / (B1/EP) BRINKMANN U ET AL: "Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesothelioma and ovarian cancers", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, UNITED STATES, SWITZERLAND, GERMANY LNKD- DOI: /(SICI) ( )71:4< 638::AID-IJC21>3.0.CO;2-6, vol. 71, no. 4, 1 January 1997 ( ), pages , XP , ISSN: (B1) WO-A2-99/28471 (B1) CHOWDHURY P S ET AL: "Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 20 JAN 1998 LNKD- PUBMED: , vol. 95, no. 2, 20 January 1998 ( ), pages , XP , ISSN: (B1) GUBBELS JENNIFER AA ET AL: "Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 5, no. 1, 26 October 2006 ( ), page 50, XP , ISSN: , DOI: / (B1) HASSAN R ET AL: "ANTI-TUMOR ACTIVITY OF K1-LYSPE38QQR, AN IMMUNOTOXIN TARGETING MESOTHELIN, A CELL- SURFACE ANTIGEN OVEREXPRESSED IN OVARIAN CANCER AND MALIGNANT MESOTHELIOMA", JOURNAL OF IMMUNOTHERAPY: WITH EMPHASIS ON TUMOR IMMUNOLOGY, RAVEN PRESS,, vol. 23, no. 4, 1 July 2000 ( ), pages , XP , ISSN: (B1) HASSAN RAFFIT ET AL: "Inhibition of mesothelin-ca-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.", LUNG CANCER (AMSTERDAM, NETHERLANDS) JUN 2010, vol. 68, no. 3, June 2010 ( ), pages , ISSN: (B1) LI QIAN ET AL: "CYTOTOXIC ACTIVITY OF THE RECOMBINANT ANTI-MESOTHELIN IMMUNOTOXIN, SS1(DSFV)PE38, TOWARDS TUMOR CELL LINES ESTABLISHED FROM ASCITES OF PATIENTS WITH PERITONEAL MESOTHELIOMAS", ANTICANCER RESEARCH, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 24, no. 3A, 1 May 2004 ( ), pages

4 , XP , ISSN: (B1) NICOLAIDES NICHOLAS C ET AL: "MORAb-009, a monoclonal antibody that specifically targets mesothelin, a cell surface tumor adhesion molecule over-expressed in pancreatic, ovarian, and lung cancer and mesothelioma", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH,, vol. 48, 18 April 2007 ( ), pages , XP , ISSN: X (B1) SHEEHAN PETER F J ET AL: "EFFECTS OF HISTAMINE AND 5-HYDROXYTRYPTAMINE ON THE GROWTH RATE OF XENOGRAFTED HUMAN BRONCHOGENIC CARCINOMAS", EXPERIMENTAL AND CLINICAL PHARMACOLOGY - EKSPERIMENTAL'NAA IKLINICESKAA FARMACOLOGIA, MOSCOW, vol. 23, no. 6-7, 1 January 1996 ( ), pages , XP , ISSN: (B1) -A (B1) -A (B1) WO-A1-2009/ (B1) WO-A2-2006/ (B1) WO-A2-2006/ (B1) CHANG K ET AL: "CHARACTERIZATION OF THE ANTIGEN (CAK1) RECOGNIZED BY MONOCLONAL ANTIBODY K1 PRESENT ON OVARIAN CANCERS AND NORMAL MES0THELIUM", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER REREARCH, LNKD- DOI: /S X(08) , vol. 52, no. 1, 1 January 1992 ( ), pages , XP , ISSN: (B1) Lisens Pant Klage til Klagenemnda Administrativ prøving Innsigelse Protest / Oppreisning Sakshistorikk Statushistorie Hovedstatus Beslutningsdato, detaljstatus EP patent gjort gjeldende i Norge EP patent besluttet gjeldende i Norge EP under behandling Forespørsel om å gjøre EP patent gyldig er mottatt Korrespondanse Dato Type korrespondanse Journal beskrivelse Innkommende EP Publiseringsdokument fra EPO Utgående EP Batch Varsel om betaling av første årsavgift (3319) Utgående EP Registreringsbrev (3210) Innkommende Søknadsskjema Patent Innkommende EP Publiseringsdokument fra EPO Informasjon om ikke tilgjengelige dokumenter Betaling

5 Til betaling: Neste fornyelse/årsavgift: Betalingshistorikk: Beskrivelse / Fakturanummer Betalingsdato Beløp Betaler Status Årsavgift 9. avg. år (EP) CPA GLOBAL LTD Betalt og godkjent Årsavgift 8. avg. år (EP) Computer Patent Annuities Ltd Tandbergs Patentkontor AS Betalt og godkjent Betalt Denne oversikten kan mangle informasjon, spesielt for eldre saker, internasjonale varemerker og internasjonale design. Publikasjon(er) Lenker til publikasjoner og Norsk Patenttidende (søkbare tekstdokumenter) Oversettelse av europeisk patentskrift Norsk Patenttidende (ved meddelelse) Lenker til publikasjoner (ikke søkbare tekstdokumenter) B1/EP Hva betyr A1, B, B1, C osv?